# FDA Inspection 1208316 - Bhavna Super Speciality Eye Care - June 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/bhavna-super-speciality-eye-care/bc59170e-6044-46a0-9940-6e93d1218557
Source feed: FDA_Inspections

> FDA Inspection 1208316 for Bhavna Super Speciality Eye Care on June 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208316
- Company Name: Bhavna Super Speciality Eye Care
- Inspection Date: 2023-06-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/bhavna-super-speciality-eye-care/109a9997-77fb-4bfa-bb73-205a8f968ff3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c